CRNX Annual Working Capital
$530.21 M
+$212.75 M+67.02%
31 December 2023
Summary:
As of January 22, 2025, CRNX annual working capital is $530.21 million, with the most recent change of +$212.75 million (+67.02%) on December 31, 2023. During the last 3 years, it has risen by +$363.21 million (+217.49%). CRNX annual working capital is now at all-time high.CRNX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRNX Quarterly Working Capital
$824.02 M
+$3.63 M+0.44%
30 September 2024
Summary:
As of January 22, 2025, CRNX quarterly working capital is $824.02 million, with the most recent change of +$3.63 million (+0.44%) on September 30, 2024. Over the past year, it has increased by +$288.73 million (+53.94%). CRNX quarterly working capital is now -4.79% below its all-time high of $865.46 million, reached on March 31, 2024.CRNX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRNX Working Capital Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +67.0% | +53.9% |
3 y3 years | +217.5% | +53.9% |
5 y5 years | +234.0% | +53.9% |
CRNX Working Capital High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +67.0% | -4.8% | +226.7% |
5 y | 5-year | at high | +361.1% | -4.8% | +674.4% |
alltime | all time | at high | +4520.6% | -4.8% | +5675.3% |
Crinetics Pharmaceuticals Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $824.02 M(+0.4%) |
June 2024 | - | $820.40 M(-5.2%) |
Mar 2024 | - | $865.46 M(+63.2%) |
Dec 2023 | $530.21 M(+67.0%) | $530.21 M(-1.0%) |
Sept 2023 | - | $535.30 M(+112.3%) |
June 2023 | - | $252.20 M(-9.6%) |
Mar 2023 | - | $279.08 M(-12.1%) |
Dec 2022 | $317.46 M(-3.4%) | $317.46 M(-10.3%) |
Sept 2022 | - | $353.77 M(-9.3%) |
June 2022 | - | $390.17 M(+26.7%) |
Mar 2022 | - | $307.99 M(-6.3%) |
Dec 2021 | $328.73 M | $328.73 M(+71.6%) |
Sept 2021 | - | $191.53 M(-4.0%) |
June 2021 | - | $199.44 M(+35.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $147.54 M(-11.7%) |
Dec 2020 | $167.00 M(+45.2%) | $167.00 M(-9.9%) |
Sept 2020 | - | $185.29 M(-7.7%) |
June 2020 | - | $200.74 M(+88.7%) |
Mar 2020 | - | $106.41 M(-7.5%) |
Dec 2019 | $115.00 M(-27.6%) | $115.00 M(-9.8%) |
Sept 2019 | - | $127.52 M(-8.9%) |
June 2019 | - | $140.01 M(-6.8%) |
Mar 2019 | - | $150.30 M(-5.3%) |
Dec 2018 | $158.76 M(+1012.7%) | $158.76 M(-4.1%) |
Sept 2018 | - | $165.53 M(+157.4%) |
June 2018 | - | $64.31 M(-10.2%) |
Mar 2018 | - | $71.59 M(+401.8%) |
Dec 2017 | $14.27 M(+24.3%) | $14.27 M |
Dec 2016 | $11.47 M | - |
FAQ
- What is Crinetics Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals annual working capital year-on-year change?
- What is Crinetics Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly working capital year-on-year change?
What is Crinetics Pharmaceuticals annual working capital?
The current annual working capital of CRNX is $530.21 M
What is the all time high annual working capital for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual working capital is $530.21 M
What is Crinetics Pharmaceuticals annual working capital year-on-year change?
Over the past year, CRNX annual working capital has changed by +$212.75 M (+67.02%)
What is Crinetics Pharmaceuticals quarterly working capital?
The current quarterly working capital of CRNX is $824.02 M
What is the all time high quarterly working capital for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly working capital is $865.46 M
What is Crinetics Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, CRNX quarterly working capital has changed by +$288.73 M (+53.94%)